Dr Reddy's Labs Switzerland incorporates wholly-owned subsidiary in Denmark
Hyderabad: Dr Reddy's Labs has announced that Dr Reddy's Laboratories SA, Switzerland, ("DRSA") a wholly-owned subsidiary of the Company has incorporated a new wholly-owned subsidiary in Denmark, named “Dr. Reddy's Denmark ApS” on October 4, 2024.
DRSA will be paying cash consideration to the Dr. Reddy's Denmark ApS towards subscription of 100% shareholding.
Dr. Reddy's Denmark ApS is yet to commence its business operations.
Established in 1984, Dr. Reddy’s Laboratories Ltd. is a global pharmaceutical company headquartered in Hyderabad, India. The Company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr Reddy's Labs major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.